amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet
amlodipine
RxCUI: 848131
What the CMS Formulary Data Shows for amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet
Per the CMS 2026 Part D formulary file, amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet (RxNorm concept RXCUI 848131, generic name amlodipine) appears on 177 distinct formulary files spanning 2,970 Medicare Part D plan offerings - 58.6% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.6.
Real-world access to amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 44.1% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 11,575,402 Part D beneficiaries filled amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $407,233,375 and an average per-beneficiary annual cost of $35.18. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 177
- Plans covering
- 2,970
- Coverage rate
- 58.6%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 44.1% of formularies
2023 Medicare Spending
- Beneficiaries
- 11,575,402
- Total spending
- $407,233,375
- Avg per beneficiary
- $35.18
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet covered by Medicare Part D?
Yes, amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet is covered by 2,970 Medicare Part D plans (58.6% of all Part D formularies).
What tier is amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet on Medicare Part D plans?
amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet averages Tier 2.6 across Part D plans, ranging from Tier 1 to Tier 6.
Does amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet. Step therapy: 0%. Quantity limits: 44.1%.
How much does Medicare spend on amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet?
In 2023, total Medicare Part D spending on amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet was $407,233,375, covering 11,575,402 beneficiaries. The average spend per beneficiary was $35.18.
Read our methodology - how this data is sourced, computed, and verified.